Copyright
©The Author(s) 2025.
World J Diabetes. Jun 15, 2025; 16(6): 107017
Published online Jun 15, 2025. doi: 10.4239/wjd.v16.i6.107017
Published online Jun 15, 2025. doi: 10.4239/wjd.v16.i6.107017
Table 1 Main molecular targets and mechanisms of action of curcumol
Molecular target | Normal function | Changes in DR | Regulatory effect of curcumol | Downstream pathological impact | Ref. |
FTO protein | m6A demethylase; regulates RNA stability and expression | Abnormal expression under high-glucose conditions; significantly elevated in fibrovascular vitreous membranes of proliferative DR patients | Increases FTO expression, activating its demethylase activity | Stabilizes MAFG-AS1 expression, inhibits endothelial inflammation and vascular leakage | Rong et al[1] |
MAFG-AS1 | Long non-coding RNA involved in metabolism and inflammation regulation | Increased m6A modification and decreased stability under high-glucose conditions | Stabilizes MAFG-AS1 through FTO-mediated demethylation | Suppresses high glucose-induced endothelial proliferation, migration, and inflammation | Rong et al[1] |
Histone lactylation | Epigenetic modification regulating gene expression | Lactate-mediated histone lactylation upregulates FTO expression | Possibly indirectly regulates FTO expression via modulation of histone lactylation | Forms a more complex epigenetic regulatory network, influencing retinal vascular integrity | Chen et al[6] |
Inflammatory cytokines | Mediate immune responses and tissue repair | Elevated pro-inflammatory cytokines (TNF-α, IL-6), triggering chronic inflammation | Downregulates IκBα, cyclooxygenase-2, prostaglandin E2, and multiple interleukins | Reduces retinal inflammation, protecting retinal neurons and vascular function | Franzone et al[50] |
Blood-retinal barrier components | Maintain homeostasis in the retinal microenvironment | Reduced cadherin and tight junction protein ZO-1 expression, impairing barrier function | Restores endothelial-specific cadherin and ZO-1 expression | Reduces vascular leakage, protecting retinal neurons from damage | Chen et al[6] |
- Citation: Luo C, Zheng ZG, Zeng MQ, Xu H, Yu XM, Sun D, He DJ. Curcumol targets the FTO/MAFG-AS1 axis to alleviate diabetic retinopathy via epigenetic remodeling and nanodelivery-based microenvironment modulation. World J Diabetes 2025; 16(6): 107017
- URL: https://www.wjgnet.com/1948-9358/full/v16/i6/107017.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i6.107017